Researchers at Washington University School of Medicine in St. Louis have discovered a molecule in the lungs of tuberculosis (TB) patients that reflects the levels of TB-causing bacteria in the lungs, information needed to better address the notoriously difficult to treat disease. Read Here.
Attached below is the updated WHO guidelines which contains a revision of the 6-Month MDR-TB regimen for adults.
The much-anticipated rollout of the shorter regimen to treat drug-resistant tuberculosis (TB) has failed to make inroads leaving patients stranded across the country. Having started in March last year
Mycobacterium tuberculosis (Mtb) has an unexpected vulnerability that future drugs may be able to exploit, according to a study from researchers at Weill Cornell Medicine. Read Here.